Brittany Schuck, Ph.D. is a Scientific Reviewer in the Office of In Vitro Diagnostics and Radiological Health (OIR) in the Center for Devices and Radiological Health at the U.S. Food and Drug Administration (FDA). In her current position, Brittany contributes scientific expertise to the review of pre- and post-market regulatory submissions to assure that patients have access to safe, effective, and high-quality in vitro diagnostic devices. Brittany specializes in regulatory review of cardiac biomarker- and genetics-based in vitro diagnostic devices. Brittany is also involved in OIR’s efforts to foster innovation and advance regulatory science of in vitro diagnostic devices for personalized medicine.

Prior to joining the FDA, Brittany completed her Ph.D. in Pharmaceutical Sciences at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy and a postdoctoral fellowship at the National Institutes of Health’s National Center for Advancing Translational Sciences.


Current Events
  • Moderator, MedtechVISION 2019Innovation Beyond R&D: Novel Approaches to Commercialization
Note: Speaker biographies were written at time of speaking engagement and may not reflect their current job title and position.
View All